Proteomic profile of circulating immune complexes in chronic Chagas disease

K Ohyama1,2, N T Huy3, H Yoshimi1

  • 1Course of Pharmaceutical Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

Parasite Immunology
|May 26, 2016
PubMed

Insights

Immune complexome analysis identified Trypanosoma cruzi and human autoantigens in Chagas disease patients. Specific antigens distinguished between indeterminate and determinate forms, revealing differences in immune status.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Parasitology

Background:

  • Immune complexes (ICs) are key indicators of humoral immune responses.
  • Identifying antigens in ICs can illuminate infectious disease pathology.
  • Chagas disease, caused by Trypanosoma cruzi, presents complex clinical manifestations.

Purpose of the Study:

  • To characterize antigens within circulating ICs in Chagas disease patients.
  • To differentiate antigen profiles between indeterminate and determinate forms of chronic Chagas disease.
  • To explore the utility of immune complexome analysis in understanding disease progression.

Main Methods:

  • Immune complexome analysis was performed on plasma samples.
  • Twenty seropositive Chagas disease patients (cardiac/megacolon determinate and indeterminate) were analyzed.
  • Ten seronegative individuals served as controls.

Main Results:

  • 39 T. cruzi antigens and 114 human autoantigens were identified in Chagas patients.
  • Specific T. cruzi (GP63, glucose-6-isomerase) and human autoantigens were prevalent in over 50% of patients.
  • T. cruzi trans-sialidase and human complement factor H-related protein 2 were more frequent in indeterminate cases.

Conclusions:

  • Immune complexome analysis effectively identifies pathogen and host antigens in Chagas disease.
  • Distinct antigen profiles correlate with different clinical forms of chronic Chagas disease.
  • This approach offers insights into the varying immune status associated with disease progression.